WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • November 21st, 2018 • BioPharmX Corp • Pharmaceutical preparations
Contract Type FiledNovember 21st, 2018 Company IndustryThis Warrant Exercise Agreement (this “Agreement”), dated as of November 20, 2018, is by and between BioPharmX Corporation, a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”).